Comments
Drug-maker Lupin Ltd said on Wednesday that it has got an approval from the regulator United States Food and Drugs Administration (USFDA) to manufacture and sell its generic version of hypertension drug Amlodipine/Benazepril.
The commercial shipment of the product has commenced, a Lupin note said.
Lupin shares closed up by 1.12 per cent on the BSE, at Rs 450.25 on Wednesday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.